Clinical Trials
9 trialsNCT02158507 2026-01-22
Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer
University of Alabama at Birmingham
Phase NA Completed
NCT04118062 2025-09-19
Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)
Institut Curie
Phase NA Completed
NCT05086731 2025-06-17
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer
Emory University
Phase NA Completed
NCT03715959 2025-02-25
Nipple Aspirate Fluid in Detecting Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03154190 2025-01-24
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
Phase NA Completed
NCT02266420 2024-12-03
COCABIO000
Institut Claudius Regaud
Phase NA Completed
NCT03457779 2021-10-08
Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer
Baylor Research Institute
Phase NA Completed
NCT02451735 2019-11-08
Genetic Counseling for Breast Cancer Survivors (GC for BC)
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT03609671 2019-08-28
Emotions Immunology and Breast Cancer
The Methodist Hospital Research Institute
Phase NA Completed